Choose

Symbol

Add Alert

Send Message To Sigma

Message Header *

Message Detail *

Upload Image

* Required

Send Message


16675 / +20(2)33357575

shd@sigma-capital.com

12-11-2024

Macro Group Pharmaceuticals -Macro Capital (MCRO.CA) Reports 9 Months Standalone Results

Source: EGX

Company Name : Macro Group Pharmaceuticals -Macro Capital
ISIN Code : EGS7D971C011
Currency : EGP
F/S Standalone Period : From 01/01/2024 To 30/09/2024
Net Loss : 64,442,930
F/S Standalone Period : From 01/01/2023 To 30/09/2023
Net Comparative Profit : 100,348,097
Audit Status : Reviewed
Source : Macro Group Pharmaceuticals -Macro Capital

The Financial Statements in Arabic (4,001 KB)
The Financial Statements in English (5,204 KB)

Market HighLights

EGX30

Indices

NameLastChCh%
EGX30 31,433.01 -149.38 %-0.47
EGX100 11,581.56 -56.98 %-0.49
EGX70E 8,326.58 -25.32 %-0.30
EGX30C 38,955.91 -241.63 %-0.62

Market Breadth ***

Advancing : Declining    0 : 1

shares

Advancing00%
Declining00%
Unchanged00%
Total0
T/O (EGP Mn)0000
Volume (Mn)0000
*** Equities only, OPR not Include, OTC included

Sector Ranking by Activity

Sector NameT/O (EGP Mn) Mkt %
Financial Services and Electronic Payments847.0821.49
Real Estate and Hotels814.2820.66
Industrial, Construction and Materials790.0920.05
Banks353.148.96
Chemicals242.106.14
Consumer Discretionary218.595.55
Food and Beverage177.764.51
Other133.543.39
Healthcare and Pharmaceuticals130.283.31
Transportation, Shipping and Logistics101.772.58
Energy67.941.72
Technology, Media and Telecom38.820.98
Education25.460.65